BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 38719141)

  • 1. The EFEMEREYE Study: prenatal medication exposure and ocular anomaly occurrence in EFEMERIS health database.
    Dubucs C; N'Go V; Caillet A; Cifuentes EA; Beau AB; Frémont F; Hurault-Delarue C; Courtade-Saïdi M; Damase-Michel C
    J AAPOS; 2024 Jun; 28(3):103931. PubMed ID: 38719141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drug in pregnancy: studies in the French database EFEMERIS].
    Damase-Michel C; Lacroix I; Hurault-Delarue C; Beau AB; Montastruc JL;
    Therapie; 2014; 69(1):91-100. PubMed ID: 24698193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In utero drug exposure and hearing impairment in 2-year-old children A case-control study using the EFEMERIS database.
    Foch C; Araujo M; Weckel A; Damase-Michel C; Montastruc JL; Benevent J; Durrieu G; Lacroix I
    Int J Pediatr Otorhinolaryngol; 2018 Oct; 113():192-197. PubMed ID: 30173984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prescription of drugs during pregnancy: a study using EFEMERIS, the new French database.
    Lacroix I; Hurault C; Sarramon MF; Guitard C; Berrebi A; Grau M; Albouy-Cossard C; Bourrel R; Elefant E; Montastruc JL; Damase-Michel C
    Eur J Clin Pharmacol; 2009 Aug; 65(8):839-46. PubMed ID: 19365629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. POMME: The New Cohort to Evaluate Long-Term Effects After Prenatal Medicine Exposure.
    Benevent J; Hurault-Delarue C; Araujo M; Montastruc JL; Lacroix I; Damase-Michel C
    Drug Saf; 2019 Jan; 42(1):45-54. PubMed ID: 30121741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prescribed opioid analgesics in early pregnancy and the risk of congenital anomalies: a population-based cohort study.
    Bowie AC; Werler MM; Velez MP; Li W; Camden A; Guttmann A; Brogly SB
    CMAJ; 2022 Feb; 194(5):E152-E162. PubMed ID: 35131753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atropinic burden of drugs during pregnancy and psychological development of children: a cohort study in the EFEMERIS database.
    Beau AB; Montastruc JL; Lacroix I; Montastruc F; Hurault-Delarue C; Damase-Michel C
    Br J Clin Pharmacol; 2016 Aug; 82(2):478-86. PubMed ID: 27085086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valproic acid monotherapy in pregnancy and major congenital malformations.
    Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
    N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of Pregnancy Termination and Congenital Anomalies After Domperidone Exposure: A Study in the EFEMERIS Database.
    Araujo M; Vabre C; Benevent J; Sommet A; Damase-Michel C; Hurault-Delarue C; Lacroix I
    Drug Saf; 2021 Jul; 44(7):787-796. PubMed ID: 33970448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies.
    Hansen C; Andrade SE; Freiman H; Dublin S; Haffenreffer K; Cooper WO; Cheetham TC; Toh S; Li DK; Raebel MA; Kuntz JL; Perrin N; Rosales AG; Carter S; Pawloski PA; Maloney EM; Graham DJ; Sahin L; Scott PE; Yap J; Davis R
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):170-8. PubMed ID: 26599424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy - a cohort linkage study.
    Garne E; Vinkel Hansen A; Morris J; Jordan S; Klungsøyr K; Engeland A; Tucker D; Thayer DS; Davies GI; Nybo Andersen AM; Dolk H
    BJOG; 2016 Sep; 123(10):1609-18. PubMed ID: 27172856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [First epidemiologic data about phloroglucinol exposure during first trimester of pregnancy].
    Lacroix I; Hurault-Delarue C; Kessler S; Guitard C; Vidal S; Albouy-Cossard C; Montastruc JL; Damase-Michel C
    Gynecol Obstet Fertil; 2011 Dec; 39(12):694-7. PubMed ID: 21855385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between macrolide antibiotics prescribing during pregnancy and adverse child outcomes in the UK: population based cohort study.
    Fan H; Gilbert R; O'Callaghan F; Li L
    BMJ; 2020 Feb; 368():m331. PubMed ID: 32075790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychomotor developmental effects of prenatal exposure to psychotropic drugs: a study in EFEMERIS database.
    Hurault-Delarue C; Damase-Michel C; Finotto L; Guitard C; Vayssière C; Montastruc JL; Montastruc F; Lacroix I
    Fundam Clin Pharmacol; 2016 Oct; 30(5):476-82. PubMed ID: 27324073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study.
    Jentink J; Dolk H; Loane MA; Morris JK; Wellesley D; Garne E; de Jong-van den Berg L;
    BMJ; 2010 Dec; 341():c6581. PubMed ID: 21127116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual anomalies in young children exposed to cocaine.
    Block SS; Moore BD; Scharre JE
    Optom Vis Sci; 1997 Jan; 74(1):28-36. PubMed ID: 9148264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuraminidase inhibitors during pregnancy and risk of adverse neonatal outcomes and congenital malformations: population based European register study.
    Graner S; Svensson T; Beau AB; Damase-Michel C; Engeland A; Furu K; Hviid A; Håberg SE; Mølgaard-Nielsen D; Pasternak B; Kieler H
    BMJ; 2017 Feb; 356():j629. PubMed ID: 28246106
    [No Abstract]   [Full Text] [Related]  

  • 19. Higher intake of medications for digestive disorders in children prenatally exposed to drugs with atropinic properties.
    Benevent J; Hurault-Delarue C; Araujo M; Montastruc F; Montastruc JL; Lacroix I; Damase-Michel C
    Fundam Clin Pharmacol; 2019 Jun; 33(3):314-326. PubMed ID: 30365180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of limb deficiencies and other congenital abnormalities in children exposed in utero to calcium channel blockers.
    Sørensen HT; Czeizel AE; Rockenbauer M; Steffensen FH; Olsen J
    Acta Obstet Gynecol Scand; 2001 May; 80(5):397-401. PubMed ID: 11328214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.